These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 19874650)
1. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650 [TBL] [Abstract][Full Text] [Related]
2. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine. Pirnay SO; Abraham TT; Huestis MA Clin Chem; 2006 Sep; 52(9):1728-34. PubMed ID: 16858076 [TBL] [Abstract][Full Text] [Related]
3. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604 [TBL] [Abstract][Full Text] [Related]
4. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS. Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680 [TBL] [Abstract][Full Text] [Related]
5. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. Pizarro N; Ortuño J; Farré M; Hernández-López C; Pujadas M; Llebaria A; Joglar J; Roset PN; Mas M; Segura J; Camí J; de la Torre R J Anal Toxicol; 2002 Apr; 26(3):157-65. PubMed ID: 11991532 [TBL] [Abstract][Full Text] [Related]
6. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma. Kolbrich EA; Lowe RH; Huestis MA Clin Chem; 2008 Feb; 54(2):379-87. PubMed ID: 18089653 [TBL] [Abstract][Full Text] [Related]
7. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA. Valtier S; Phelix CF; Cody JT J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960 [TBL] [Abstract][Full Text] [Related]
8. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine. Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356 [TBL] [Abstract][Full Text] [Related]
9. Gas chromatography-ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine. da Silva DG; de Pinho PG; Pontes H; Ferreira L; Branco P; Remião F; Carvalho F; Bastos ML; Carmo H J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):815-22. PubMed ID: 20167546 [TBL] [Abstract][Full Text] [Related]
10. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH Clin Chem; 2011 Dec; 57(12):1748-56. PubMed ID: 21980168 [TBL] [Abstract][Full Text] [Related]
11. Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA. Pirnay SO; Abraham TT; Lowe RH; Huestis MA J Anal Toxicol; 2006 Oct; 30(8):563-9. PubMed ID: 17132253 [TBL] [Abstract][Full Text] [Related]
12. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse. Kikura R; Nakahara Y; Mieczkowski T; Tagliaro F Forensic Sci Int; 1997 Jan; 84(1-3):165-77. PubMed ID: 9042722 [TBL] [Abstract][Full Text] [Related]
13. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration. Hartman RL; Desrosiers NA; Barnes AJ; Yun K; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA Anal Bioanal Chem; 2014 Jan; 406(2):587-99. PubMed ID: 24232751 [TBL] [Abstract][Full Text] [Related]
14. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903 [TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats. Shima N; Katagi M; Kamata H; Zaitsu K; Kamata T; Nishikawa M; Miki A; Tsuchihashi H; Sakuma T; Nemoto N Xenobiotica; 2008 Mar; 38(3):314-24. PubMed ID: 18274959 [TBL] [Abstract][Full Text] [Related]
16. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Barnes AJ; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA Ther Drug Monit; 2011 Oct; 33(5):602-8. PubMed ID: 21860342 [TBL] [Abstract][Full Text] [Related]
17. Screening for illicit drugs in pooled human urine and urinated soil samples and studies on the stability of urinary excretion products of cocaine, MDMA, and MDEA in wastewater by hyphenated mass spectrometry techniques. Mardal M; Kinyua J; Ramin P; Miserez B; Van Nuijs AL; Covaci A; Meyer MR Drug Test Anal; 2017 Jan; 9(1):106-114. PubMed ID: 26888521 [TBL] [Abstract][Full Text] [Related]
18. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry. Pizarro N; Llebaria A; Cano S; Joglar J; Farré M; Segura J; de la Torre R Rapid Commun Mass Spectrom; 2003; 17(4):330-6. PubMed ID: 12569443 [TBL] [Abstract][Full Text] [Related]
19. A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction. Darracq MA; Thornton SL; Minns AB; Gerona RR J Psychoactive Drugs; 2016; 48(5):351-354. PubMed ID: 27636207 [TBL] [Abstract][Full Text] [Related]